Financhill
Sell
41

IOSP Quote, Financials, Valuation and Earnings

Last price:
$96.03
Seasonality move :
9.6%
Day range:
$95.17 - $98.26
52-week range:
$95.17 - $133.71
Dividend yield:
1.61%
P/E ratio:
68.58x
P/S ratio:
1.31x
P/B ratio:
1.98x
Volume:
1.5M
Avg. volume:
278.1K
1-year change:
-24.77%
Market cap:
$2.4B
Revenue:
$1.8B
EPS (TTM):
$1.40

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
IOSP
Innospec
$447.4M $1.36 -6.54% -12.53% $131.50
ALTO
Alto Ingredients
$222.8M -$0.11 -7.66% -17.65% $4.50
BCPC
Balchem
$240M $1.11 2.52% 36.52% $199.33
FRD
Friedman Industries
-- -- -- -- --
PZG
Paramount Gold Nevada
-- -$0.03 -- -- $1.40
XPL
Solitario Resources
-- -$0.02 -- -- $1.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
IOSP
Innospec
$96.01 $131.50 $2.4B 68.58x $0.79 1.61% 1.31x
ALTO
Alto Ingredients
$1.36 $4.50 $103.8M -- $0.00 0% 0.10x
BCPC
Balchem
$161.18 $199.33 $5.2B 41.01x $0.87 0.54% 5.53x
FRD
Friedman Industries
$17.20 -- $119.9M 21.23x $0.04 0.93% 0.27x
PZG
Paramount Gold Nevada
$0.38 $1.40 $25.7M -- $0.00 0% --
XPL
Solitario Resources
$0.63 $1.50 $51.8M -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
IOSP
Innospec
-- 1.651 -- 1.70x
ALTO
Alto Ingredients
29.22% -1.356 77.78% 1.62x
BCPC
Balchem
14.18% 1.260 4.12% 1.07x
FRD
Friedman Industries
20.34% -0.384 30.78% 0.78x
PZG
Paramount Gold Nevada
-- 1.921 -- --
XPL
Solitario Resources
-- -1.152 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
IOSP
Innospec
$136.2M $37.4M 2.97% 2.97% 8.01% $4.9M
ALTO
Alto Ingredients
-$1.4M -$6.7M -16.99% -22.63% -16.53% -$11.1M
BCPC
Balchem
$86.3M $47.4M 9.36% 11.53% 19.71% $39.6M
FRD
Friedman Industries
$8.1M -$1.6M 3.41% 4.48% -0.98% $1.6M
PZG
Paramount Gold Nevada
-$186.4K -$1.2M -- -- -- -$946.4K
XPL
Solitario Resources
-$6K -$1.6M -- -- -- -$1.7M

Innospec vs. Competitors

  • Which has Higher Returns IOSP or ALTO?

    Alto Ingredients has a net margin of -15.08% compared to Innospec's net margin of -17.65%. Innospec's return on equity of 2.97% beat Alto Ingredients's return on equity of -22.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    29.18% -$2.82 $1.2B
    ALTO
    Alto Ingredients
    -0.59% -$0.57 $318M
  • What do Analysts Say About IOSP or ALTO?

    Innospec has a consensus price target of $131.50, signalling upside risk potential of 36.97%. On the other hand Alto Ingredients has an analysts' consensus of $4.50 which suggests that it could grow by 232.1%. Given that Alto Ingredients has higher upside potential than Innospec, analysts believe Alto Ingredients is more attractive than Innospec.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    ALTO
    Alto Ingredients
    1 0 0
  • Is IOSP or ALTO More Risky?

    Innospec has a beta of 1.076, which suggesting that the stock is 7.631% more volatile than S&P 500. In comparison Alto Ingredients has a beta of 1.735, suggesting its more volatile than the S&P 500 by 73.514%.

  • Which is a Better Dividend Stock IOSP or ALTO?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.61%. Alto Ingredients offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec pays 108.99% of its earnings as a dividend. Alto Ingredients pays out -2.15% of its earnings as a dividend.

  • Which has Better Financial Ratios IOSP or ALTO?

    Innospec quarterly revenues are $466.8M, which are larger than Alto Ingredients quarterly revenues of $236.3M. Innospec's net income of -$70.4M is lower than Alto Ingredients's net income of -$41.7M. Notably, Innospec's price-to-earnings ratio is 68.58x while Alto Ingredients's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.31x versus 0.10x for Alto Ingredients. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.31x 68.58x $466.8M -$70.4M
    ALTO
    Alto Ingredients
    0.10x -- $236.3M -$41.7M
  • Which has Higher Returns IOSP or BCPC?

    Balchem has a net margin of -15.08% compared to Innospec's net margin of 13.99%. Innospec's return on equity of 2.97% beat Balchem's return on equity of 11.53%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    29.18% -$2.82 $1.2B
    BCPC
    Balchem
    35.97% $1.03 $1.3B
  • What do Analysts Say About IOSP or BCPC?

    Innospec has a consensus price target of $131.50, signalling upside risk potential of 36.97%. On the other hand Balchem has an analysts' consensus of $199.33 which suggests that it could grow by 23.67%. Given that Innospec has higher upside potential than Balchem, analysts believe Innospec is more attractive than Balchem.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    BCPC
    Balchem
    0 0 0
  • Is IOSP or BCPC More Risky?

    Innospec has a beta of 1.076, which suggesting that the stock is 7.631% more volatile than S&P 500. In comparison Balchem has a beta of 0.627, suggesting its less volatile than the S&P 500 by 37.287%.

  • Which is a Better Dividend Stock IOSP or BCPC?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.61%. Balchem offers a yield of 0.54% to investors and pays a quarterly dividend of $0.87 per share. Innospec pays 108.99% of its earnings as a dividend. Balchem pays out 19.91% of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Innospec's is not.

  • Which has Better Financial Ratios IOSP or BCPC?

    Innospec quarterly revenues are $466.8M, which are larger than Balchem quarterly revenues of $240M. Innospec's net income of -$70.4M is lower than Balchem's net income of $33.6M. Notably, Innospec's price-to-earnings ratio is 68.58x while Balchem's PE ratio is 41.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.31x versus 5.53x for Balchem. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.31x 68.58x $466.8M -$70.4M
    BCPC
    Balchem
    5.53x 41.01x $240M $33.6M
  • Which has Higher Returns IOSP or FRD?

    Friedman Industries has a net margin of -15.08% compared to Innospec's net margin of -1.23%. Innospec's return on equity of 2.97% beat Friedman Industries's return on equity of 4.48%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    29.18% -$2.82 $1.2B
    FRD
    Friedman Industries
    8.6% -$0.17 $159.8M
  • What do Analysts Say About IOSP or FRD?

    Innospec has a consensus price target of $131.50, signalling upside risk potential of 36.97%. On the other hand Friedman Industries has an analysts' consensus of -- which suggests that it could fall by --. Given that Innospec has higher upside potential than Friedman Industries, analysts believe Innospec is more attractive than Friedman Industries.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    FRD
    Friedman Industries
    0 0 0
  • Is IOSP or FRD More Risky?

    Innospec has a beta of 1.076, which suggesting that the stock is 7.631% more volatile than S&P 500. In comparison Friedman Industries has a beta of 1.417, suggesting its more volatile than the S&P 500 by 41.675%.

  • Which is a Better Dividend Stock IOSP or FRD?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.61%. Friedman Industries offers a yield of 0.93% to investors and pays a quarterly dividend of $0.04 per share. Innospec pays 108.99% of its earnings as a dividend. Friedman Industries pays out 3.35% of its earnings as a dividend. Friedman Industries's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Innospec's is not.

  • Which has Better Financial Ratios IOSP or FRD?

    Innospec quarterly revenues are $466.8M, which are larger than Friedman Industries quarterly revenues of $94.1M. Innospec's net income of -$70.4M is lower than Friedman Industries's net income of -$1.2M. Notably, Innospec's price-to-earnings ratio is 68.58x while Friedman Industries's PE ratio is 21.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.31x versus 0.27x for Friedman Industries. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.31x 68.58x $466.8M -$70.4M
    FRD
    Friedman Industries
    0.27x 21.23x $94.1M -$1.2M
  • Which has Higher Returns IOSP or PZG?

    Paramount Gold Nevada has a net margin of -15.08% compared to Innospec's net margin of --. Innospec's return on equity of 2.97% beat Paramount Gold Nevada's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    29.18% -$2.82 $1.2B
    PZG
    Paramount Gold Nevada
    -- -$0.03 --
  • What do Analysts Say About IOSP or PZG?

    Innospec has a consensus price target of $131.50, signalling upside risk potential of 36.97%. On the other hand Paramount Gold Nevada has an analysts' consensus of $1.40 which suggests that it could grow by 267.65%. Given that Paramount Gold Nevada has higher upside potential than Innospec, analysts believe Paramount Gold Nevada is more attractive than Innospec.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    PZG
    Paramount Gold Nevada
    1 0 0
  • Is IOSP or PZG More Risky?

    Innospec has a beta of 1.076, which suggesting that the stock is 7.631% more volatile than S&P 500. In comparison Paramount Gold Nevada has a beta of 1.923, suggesting its more volatile than the S&P 500 by 92.323%.

  • Which is a Better Dividend Stock IOSP or PZG?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.61%. Paramount Gold Nevada offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec pays 108.99% of its earnings as a dividend. Paramount Gold Nevada pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IOSP or PZG?

    Innospec quarterly revenues are $466.8M, which are larger than Paramount Gold Nevada quarterly revenues of --. Innospec's net income of -$70.4M is lower than Paramount Gold Nevada's net income of -$2M. Notably, Innospec's price-to-earnings ratio is 68.58x while Paramount Gold Nevada's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.31x versus -- for Paramount Gold Nevada. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.31x 68.58x $466.8M -$70.4M
    PZG
    Paramount Gold Nevada
    -- -- -- -$2M
  • Which has Higher Returns IOSP or XPL?

    Solitario Resources has a net margin of -15.08% compared to Innospec's net margin of --. Innospec's return on equity of 2.97% beat Solitario Resources's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    29.18% -$2.82 $1.2B
    XPL
    Solitario Resources
    -- -$0.02 --
  • What do Analysts Say About IOSP or XPL?

    Innospec has a consensus price target of $131.50, signalling upside risk potential of 36.97%. On the other hand Solitario Resources has an analysts' consensus of $1.50 which suggests that it could grow by 136.52%. Given that Solitario Resources has higher upside potential than Innospec, analysts believe Solitario Resources is more attractive than Innospec.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    XPL
    Solitario Resources
    0 0 0
  • Is IOSP or XPL More Risky?

    Innospec has a beta of 1.076, which suggesting that the stock is 7.631% more volatile than S&P 500. In comparison Solitario Resources has a beta of 0.921, suggesting its less volatile than the S&P 500 by 7.928%.

  • Which is a Better Dividend Stock IOSP or XPL?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.61%. Solitario Resources offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec pays 108.99% of its earnings as a dividend. Solitario Resources pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IOSP or XPL?

    Innospec quarterly revenues are $466.8M, which are larger than Solitario Resources quarterly revenues of --. Innospec's net income of -$70.4M is lower than Solitario Resources's net income of -$1.6M. Notably, Innospec's price-to-earnings ratio is 68.58x while Solitario Resources's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.31x versus -- for Solitario Resources. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.31x 68.58x $466.8M -$70.4M
    XPL
    Solitario Resources
    -- -- -- -$1.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock